nach oben

Neurosurgical Review

Erschienen in:

14.11.2017 | Review

Multiple high-grade gliomas: epidemiology, management, and outcome. A systematic review and meta-analysis

verfasst von: Davide Tiziano Di Carlo, Federico Cagnazzo, Nicola Benedetto, Riccardo Morganti, Paolo Perrini

Erschienen in: Neurosurgical Review | Ausgabe 2/2019

Einloggen, um Zugang zu erhalten

Abstract

Multiple high-grade gliomas (M-HGGs) are well--separated tumors, differentiated as multifocal (MF) and multicentric (MC) by their MRI features. The authors performed a systematic review and meta-analysis of literature examining epidemiology, clinical and radiological characteristics, management, and the overall survival from M-HGGs. According to PRISMA guidelines, a comprehensive review of studies published between January 1990 and January 2017 was carried out. The authors identified studies that examined the prevalence rate, clinical and radiological characteristics, treatment, and overall survival from M-HGGs in patients with HGG. Data were analyzed using a random-effects meta-analysis model. Finally, we systematically reviewed demographic characteristics, lesion location, and surgical and adjuvant treatments. Twenty-three studies were included in this systematic review. The M-HGGs prevalence rate was 19% (95% CI 13–26%) and the hazard ratio of death from M-HGGs in the HGGs population was 1.71 (95% CI 1.49–1.95, p < 0.0001). The MC prevalence rate was 6% (CI 95% 4–10%), whereas MF prevalence rate was 11% (CI 95% 6–20%) (p < 0.0001). There were no statistically significant differences between MF and MC HGGs in gender, lesion location, histological type, and surgical treatment. Survival analysis of MC tumors showed that surgical resection (gross total resection or subtotal resection) is an independent predictor of improved outcome (HR 7.61 for biopsy subgroup, 95% CI 1.94–29.78, p = 0.004). The prevalence of M-HGGs is approximately 20% of HGGs. The clinical relevance of separating M-HGGs in MF and MC tumors remains questionable and its prognostic significance is unclear. When patient status and lesion characteristics make it safe and feasible, cytoreduction should be attempted in patients with M-HGGs because it improves overall survival.

Nur mit Berechtigung zugänglich

Akimoto J, Sasaki H, Haraoka R, Nakajima N, Fukami S, Kohno M (2014) A case of radiologically multicentric but genetically identical multiple glioblastomas. Brain Tumor Pathol 31:113–117. https://doi.org/10.1007/s10014-013-0157-x CrossRefPubMed

Arcos A, Romero L, Serramito R, Santín JM, Prieto A, Gelabert M, Arráez MÁ, Ángel M (2012) Multicentric glioblastoma multiforme. Report of 3 cases, clinical and pathological study and literature review. Neurocirugia (Astur) 23:211–215. https://doi.org/10.1016/j.neucir.2012.06.004 CrossRef

Arvold ND, Tanguturi SK, Aizer AA, Wen PY, Reardon DA, Lee EQ, Nayak L, Christianson LW, Horvath MC, Dunn IF, Golby AJ, Johnson MD, Claus EB, Chiocca EA, Ligon KL, Alexander BM (2015) Hypofractionated versus standard radiation therapy with or without temozolomide for older glioblastoma patients. Int J Radiat Oncol Biol Phys 92:384–389. https://doi.org/10.1016/j.ijrobp.2015.01.017 CrossRefPubMed

Banan R, Hartmann C (2017) The new WHO 2016 classification of brain tumors—what neurosurgeons need to know. Acta Neurochir (Wien) 1–16. doi: https://doi.org/10.1007/s00701-016-3062-3

Batzdorf U, Malamud N (1963) The problem of multicentric gliomas. J Neurosurg 20:122–136. https://doi.org/10.3171/jns.1963.20.2.0122 CrossRefPubMed

Bloch O, Han SJ, Cha S, Sun MZ, Aghi MK, McDermott MW, Berger MS, Parsa AT (2012) Impact of extent of resection for recurrent glioblastoma on overall survival: clinical article. J Neurosurg 117:1032–1038. https://doi.org/10.3171/2012.9.JNS12504 CrossRef

Bradley W (1880) Case of gliosarcomatous tumors of the brain. Proc Conn Med Soc

Cuddapah VA, Robel S, Watkins S, Sontheimer H (2014) A neurocentric perspective on glioma invasion. Nat Publ Gr 15:455–465. https://doi.org/10.1038/nrn3765 CrossRef

Djalilian HR, Shah MV, Hall WA (1999) Radiographic incidence of multicentric malignant gliomas. Surg Neurol 51:554–558. https://doi.org/10.1016/S0090-3019(98)00054-8 CrossRefPubMed

10.

Fares Y, Younes M, Kanj A, Ruiz Barnes P, Muñiz J (2009) Multicentric glioma. P R Health Sci J 28:75–79PubMed

11.

Giese A, Bjerkvig R, Berens ME, Westphal M (2003) Cost of migration: invasion of malignant gliomas and implications for treatment. J Clin Oncol 21:1624–1636. https://doi.org/10.1200/JCO.2003.05.063 CrossRefPubMed

12.

Globus J, Kuhlenbeck H (1944) The subependymal cell plate (matrix) and its relationship to brain tumors of the ependymal type. J. Neuropathol

13.

Gulati S, Jakola AS, Nerland US, Weber C, Solheim O (2011) The risk of getting worse: surgically acquired deficits, perioperative complications, and functional outcomes after primary resection of glioblastoma. World Neurosurg 76:572–579. https://doi.org/10.1016/j.wneu.2011.06.014 CrossRefPubMed

14.

Hartmann C, Hentschel B, Simon M, Westphal M, Schackert G, Tonn JC, Loeffler M, Reifenberger G, Pietsch T, Von Deimling A, Weller M (2013) Long-term survival in primary glioblastoma with versus without isocitrate dehydrogenase mutations. Clin Cancer Res 19:5146–5157. https://doi.org/10.1158/1078-0432.CCR-13-0017 CrossRefPubMed

15.

Hassaneen W, Levine NB, Suki D, Salaskar AL, de Moura LA, McCutcheon IE, Prabhu SS, Lang FF, DeMonte F, Rao G, Weinberg JS, Wildrick DM, Aldape KD, Sawaya R (2011) Multiple craniotomies in the management of multifocal and multicentric glioblastoma. Clinical article. J Neurosurg 114:576–584. https://doi.org/10.3171/2010.6.JNS091326 CrossRefPubMed

16.

Hefti M, Von Campe G, Schneider C, Roelcke U, Landolt H, Article O, Hefti M, Von Campe G, Schneider C, Roelcke U, Landolt H (2010) Multicentric tumor manifestations of high grade gliomas: Independent proliferation or hallmark of extensive disease? Zentralbl Neurochir 71:103. https://doi.org/10.1055/s-0029-1241190 CrossRef

17.

Higgins JPT, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ Br Med J 327:557–560. https://doi.org/10.1136/bmj.327.7414.557 CrossRef

18.

Karlowee V, Amatya VJ, Hirano H, Takayasu T, Nosaka R, Kolakshyapati M, Yoshihiro M, Takeshima Y, Sugiyama K, Arita K, Kurisu K, Yamasaki F (2016) Multicentric glioma develops via a mutant IDH1-independent pathway: immunohistochemical study of multicentric glioma. Pathobiology:4–8. https://doi.org/10.1159/000447951

19.

Karnofsky DA, Abelmann WH, Craver LF, Burchenal JH (1948) The use of the nitrogen mustards in the palliative treatment of carcinoma. Cancer 1:634–656. https://doi.org/10.1002/1097-0142(194811)1:4<634::AID-CNCR2820010410>3.0.CO;2-L CrossRef

20.

Kato T, Aida T, Abe H, Ogata A, Nakamura N, Nagashima K, Kitaoka K (1990) Clinicopathological study of multiple gliomas—report of three cases. Neurol Med Chir (Tokyo) 30:604–609CrossRef

21.

Khan MB, Chakraborty S, Boockvar JA (2016) Gross total resection of glioblastoma improves overall survival and progression-free survival compared to subtotal resection or biopsy alone. Neurosurgery 79:N12–N13. https://doi.org/10.1227/01.neu.0000508600.08200.c1 CrossRef

22.

Kong D-S, Kim J, Lee I-H, Kim ST, Seol HJ, Lee J-I, Park W-Y, Ryu G, Wang Z, Ma’ayan A, Nam D-H (2016) Integrative radiogenomic analysis for multicentric radiophenotype in glioblastoma. Oncotarget 7:11526–11538. 10.18632/oncotarget.7115 CrossRefPubMedPubMedCentral

23.

Kreth FW, Thon N, Simon M, Westphal M, Schackert G, Nikkhah G, Hentschel B, Reifenberger G, Pietsch T, Weller M, Tonn JC (2013) Gross total but not incomplete resection of glioblastoma prolongs survival in the era of radiochemotherapy. Ann Oncol 24:3117–3123. https://doi.org/10.1093/annonc/mdt388 CrossRefPubMed

24.

Krex D, Mohr B, Appelt H, Schackert HK, Schackert G, Waziri AE, Bruce JN, Ph D, Schackert G, Al ET, Appelt H, Schackert HK, Schackert G, Waziri AE, Bruce JN (2003) Genetic analysis of a multifocal glioblastoma multiforme: a suitable tool to gain new aspects in glioma development. Neurosurgery 53:1377–1384. https://doi.org/10.1227/01.NEU.0000093426.29236.86 CrossRefPubMed

25.

Kuhnt D, Becker A, Ganslandt O, Bauer M, Buchfelder M, Nimsky C (2011) Correlation of the extent of tumor volume resection and patient survival in surgery of glioblastoma multiforme with high-field intraoperative MRI guidance. Neuro-Oncology 13:1339–1348. https://doi.org/10.1093/neuonc/nor133 CrossRefPubMedPubMedCentral

26.

Kyritsis AP, Levin VA, Alfred Yung WK, Leeds NE (1993) Imaging patterns of multifocal gliomas. Eur J Radiol 16:163–170. https://doi.org/10.1016/0720-048X(93)90063-S CrossRefPubMed

27.

Lacroix M, Abi-Said D, Fourney DR, Gokaslan ZL, Shi W, DeMonte F, Lang FF, McCutcheon IE, Hassenbusch SJ, Holland E, Hess K, Michael C, Miller D, Sawaya R (2001) A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. J Neurosurg 95:190–198. https://doi.org/10.3171/jns.2001.95.2.0190 CrossRef

28.

Lasocki A, Gaillard F, Tacey MA, Drummond KJ, Stuckey SL (2016) The incidence and significance of multicentric noncontrast-enhancing lesions distant from a histologically-proven glioblastoma. J Neuro-Oncol 129:471–478. https://doi.org/10.1007/s11060-016-2193-y CrossRef

29.

Lasocki A, Gaillard F, Tacey M, Drummond K, Stuckey S (2016) Multifocal and multicentric glioblastoma: improved characterisation with FLAIR imaging and prognostic implications. J Clin Neurosci 31:92–98. https://doi.org/10.1016/j.jocn.2016.02.022 CrossRefPubMed

30.

Laws ER, Parney IF, Huang W, Anderson F, Morris AM, Asher A, Lillehei KO, Bernstein M, Brem H, Sloan A, Berger MS, Chang S, Tumor B (2003) Survival following surgery and prognostic factors for recently diagnosed malignant glioma: data from the glioma outcomes project. J Neurosurg 99:467–473. https://doi.org/10.3171/jns.2003.99.3.0467 CrossRefPubMed

31.

Lim DA, Cha S, Mayo MC, Chen M-HH, Keles E, Vanden Berg S, Berger MS (2007) Relationship of glioblastoma multiforme to neural stem cell regions predicts invasive and multifocal tumor phenotype. Neuro-Oncology 9:424–429. https://doi.org/10.1215/15228517-2007-023 CrossRefPubMedPubMedCentral

32.

Liu Q, Liu Y, Li W, Wang X, Sawaya R, Lang FF, Yung WKA, Chen K, Fuller GN, Zhang W (2015) Genetic, epigenetic, and molecular landscapes of multifocal and multicentric glioblastoma. Acta Neuropathol 130:587–597. https://doi.org/10.1007/s00401-015-1470-8 CrossRefPubMedPubMedCentral

33.

Moher D, Liberati A, Tetzlaff J, Altman DG, Grp P (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement (reprinted from annals of internal medicine). Phys Ther 89:873–880. https://doi.org/10.1371/journal.pmed.1000097 CrossRef

34.

Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, Carbone PP (1982) Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5:649–655CrossRefPubMed

35.

Orringer D, Lau D, Khatri S, Zamora-Berridi GJ, Zhang K, Wu C, Chaudhary N, Sagher O (2012) Extent of resection in patients with glioblastoma: limiting factors, perception of resectability, and effect on survival. J Neurosurg 117:851–859. https://doi.org/10.3171/2012.8.JNS12234 CrossRefPubMed

36.

Parsa AT, Wachhorst S, Lamborn KR, Prados MD, McDermott MW, Berger MS, Chang SM, Francisco S (2005) Prognostic significance of intracranial dissemination of glioblastoma multiforme in adults. J Neurosurg 102:622–628. https://doi.org/10.3171/jns.2005.102.4.0622 CrossRefPubMed

37.

Patil CG, Eboli P, Hu J (2012) Management of multifocal and multicentric gliomas. Neurosurg Clin N Am 23:343–350. https://doi.org/10.1016/j.nec.2012.01.012 CrossRefPubMed

38.

Patil CG, Yi A, Elramsisy A, Hu J, Mukherjee D, Irvin DK, Yu JS, Bannykh SI, Black KL, Nuño M, Angeles L (2012) Prognosis of patients with multifocal glioblastoma: a case-control study. J Neurosurg 117:705–711. https://doi.org/10.3171/2012.7.JNS12147 CrossRef

39.

Paulsson AK, Holmes JA, Peiffer AM, Miller LD, Liu W, Xu J, Hinson WH, Lesser GJ, Laxton AW, Tatter SB, Debinski W, Chan MD (2014) Comparison of clinical outcomes and genomic characteristics of single focus and multifocal glioblastoma. J Neuro-Oncol 119:429–435. https://doi.org/10.1007/s11060-014-1515-1 CrossRef

40.

R. Stupp, W. P. Mason MJ van den B et al. (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma, N Engl J Med vol 352, no 10 987–996.

41.

Russel D, Rubinstein S (1989) Pathol Tumours Nerv Syst 702:145–147. https://doi.org/10.1136/pgmj.35.410.702 CrossRef

42.

di Russo P, Perrini P, Pasqualetti F, Meola A, Vannozzi R (2013) Management and outcome of high-grade multicentric gliomas: a contemporary single-institution series and review of the literature. Acta Neurochir 155:2245–2251. https://doi.org/10.1007/s00701-013-1892-9 CrossRefPubMed

43.

Salvati M, Caroli E, Orlando ER, Frati A, Artizzu S, Ferrante L (2003) Multicentric glioma: our experience in 25 patients and critical review of the literature. Neurosurg Rev 26:275–279. https://doi.org/10.1007/s10143-003-0276-7 CrossRefPubMed

44.

Sanai N, Berger MS (2008) Glioma extent of resection and its impact on patient outcome. Neurosurgery 62:753–764. https://doi.org/10.1227/01.neu.0000318159.21731.cf CrossRef

45.

Scott JG, Suh JH, Elson P, Barnett GH, Vogelbaum MA, Peereboom DM, Stevens GHJ, Elinzano H, Chao ST (2011) Aggressive treatment is appropriate for glioblastoma multiforme patients 70 years old or older: a retrospective review of 206 cases. Neuro-Oncology 13:428–436. https://doi.org/10.1093/neuonc/nor005 CrossRefPubMedPubMedCentral

46.

Selbekk T, Jakola AS, Solheim O, Johansen TF, Lindseth F, Reinertsen I, Unsgård G (2013) Ultrasound imaging in neurosurgery: approaches to minimize surgically induced image artefacts for improved resection control. Acta Neurochir 155:973–980. https://doi.org/10.1007/s00701-013-1647-7 CrossRefPubMed

47.

Showalter TN, Andrel J, Andrews DW, Curran WJ, Daskalakis C, Werner-Wasik M (2007) Multifocal glioblastoma multiforme: prognostic factors and patterns of progression. Int J Radiat Oncol Biol Phys 69:820–824. https://doi.org/10.1016/j.ijrobp.2007.03.045 CrossRef

48.

Stark AM, Van De Bergh J, Hedderich J, Mehdorn HM, Nabavi A (2012) Glioblastoma: clinical characteristics, prognostic factors and survival in 492 patients. Clin Neurol Neurosurg 114:840–845. https://doi.org/10.1016/j.clineuro.2012.01.026 CrossRefPubMed

49.

Tanaka S, Meyer FB, Buckner JC, Uhm JH, Yan ES, Parney IF, Clinic M (2013) Presentation, management, and outcome of newly diagnosed glioblastoma in elderly patients. J Neurosurg 118:786–798. https://doi.org/10.3171/2012.10.JNS112268 CrossRefPubMed

50.

Taylor MD, Bernstein M (1999) Awake craniotomy with brain mapping as the routine surgical approach to treating patients with supratentorial intraaxial tumors: a prospective trial of 200 cases. J Neurosurg 90:35–41. https://doi.org/10.3171/jns.1999.90.1.0035 CrossRefPubMed

51.

Thomas RP, Xu LW, Lober RM, Li G, Nagpal S (2013) The incidence and significance of multiple lesions in glioblastoma. J Neuro-Oncol 112:91–97. https://doi.org/10.1007/s11060-012-1030-1 CrossRef

52.

Verger E, Salamero M, Conill C (1992) Can Karnofsky performance status be transformed to the eastern cooperative oncology group scoring scale and vice versa? Eur J Cancer 28:1328–1330. https://doi.org/10.1016/0959-8049(92)90510-9 CrossRef

53.

Wells GA, Shea B, O’Connell D, Peterson J, Welch V, Losos M, Tugwell P (2013) The Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses. Ottawa Hosp Res Inst 1–4. doi: https://doi.org/10.2307/632432

54.

Wen PY, Macdonald DR, Reardon DA, Cloughesy TF, Sorensen AG, Galanis E, DeGroot J, Wick W, Gilbert MR, Lassman AB, Tsien C, Mikkelsen T, Wong ET, Chamberlain MC, Stupp R, Lamborn KR, Vogelbaum MA, Van Den Bent MJ, Chang SM (2010) Updated response assessment criteria for high-grade gliomas: Response assessment in neuro-oncology working group. J Clin Oncol 28:1963–1972. https://doi.org/10.1200/JCO.2009.26.3541 CrossRefPubMed

Titel: Multiple high-grade gliomas: epidemiology, management, and outcome. A systematic review and meta-analysis
verfasst von: Davide Tiziano Di Carlo
Federico Cagnazzo
Nicola Benedetto
Riccardo Morganti
Paolo Perrini
Publikationsdatum: 14.11.2017
Verlag: Springer Berlin Heidelberg
Erschienen in: Neurosurgical Review / Ausgabe 2/2019
Print ISSN: 0344-5607
Elektronische ISSN: 1437-2320
DOI: https://doi.org/10.1007/s10143-017-0928-7

Neu im Fachgebiet Chirurgie

23.04.2024 | Ablationstherapie | Nachrichten

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

23.04.2024 | Appendizitis | Nachrichten

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 | Operationsvorbereitung | Nachrichten

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

19.04.2024 | EAU 2024 | Kongressbericht | Nachrichten

Ureterstriktur: Innovative OP-Technik bewährt sich

weitere anzeigen

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Aktuelle BDC Leitlinien-Webinare

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare

CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare

CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske

Dr. med. Benjamin Meyknecht

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare

CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2019

The association between collagen gene polymorphisms and intracranial aneurysms: a meta-analysis

Correction to: Efficacy of superficial temporal artery-middle cerebral artery double bypass in patients with hemorrhagic moyamoya disease: surgical effects for operated hemispheric sides

Intradural spinal tumors in adults—update on management and outcome

Evaluation of the risk of rupture of intracranial aneurysms in patients with aneurysmal subarachnoid hemorrhage according to the PHASES score

Pseudarthrosis in adult and pediatric spinal deformity surgery: a systematic review of the literature and meta-analysis of incidence, characteristics, and risk factors

What is the best therapeutic approach to a pediatric patient with a deep-seated brain AVM?

Neu im Fachgebiet Chirurgie

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

Hinter dieser Appendizitis steckte ein Erreger

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

Ureterstriktur: Innovative OP-Technik bewährt sich

Update Chirurgie

Aktuelle BDC Leitlinien-Webinare

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

S2e-Leitlinie „Distale Radiusfraktur“

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“